176 results
Page 2 of 9
6-K
EX-99.1
009nqm12zp
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
6-K
EX-99.2
j7h76n8p
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
vf0ebep1mvs8sixa95x
2 Aug 23
Report of Foreign Private Issuer
8:05am
6-K
EX-99.1
74fuxec3 0zei3uu8
31 Jul 23
Enlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis
8:05am
6-K
EX-99.1
erzlck
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
6-K
EX-99.2
2wkcq8
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
pxzxsx2tfw4u
31 May 23
Report of Foreign Private Issuer
8:09am
6-K
EX-99.1
qytzhc0doo0ls2p
8 May 23
Enlivex Announces Issuance of European Patent Covering the Use of Allocetra™ to
8:02am
6-K
EX-99.1
xtpvyjplrl2qn7
19 Apr 23
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
8:03am
6-K
EX-99.1
figfxesrpqath obh
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
EX-99.1
01u4 bnsfctps
4 Apr 23
Enlivex Announces Tislelizumab Clinical Collaboration, Full Year 2022 Financial Results, and Provides Business Updates
8:05am
6-K
EX-99.1
mbf kiz4o2
3 Apr 23
Enlivex Announces Clinical Collaboration to Evaluate Combinations of Allocetra and PD-1 Inhibitor Tislelizumab for Patients with Solid Tumors
8:05am
6-K
EX-99.1
6q98ujw
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
mnwcwfyw
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
w7m dg616kawxjc
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
q6lawh0 9i5muc
5 Dec 22
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
8:05am
6-K
EX-99.2
t4qjd
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
5js8fbqy
28 Nov 22
Enlivex Receives Allocetra IND Clearance From The U.S. Food And Drug Administration For Treatment Of Patients with Advanced Solid Malignancies
8:01am
6-K
EX-99.1
u3qaswlwr7po6
15 Nov 22
Report of Foreign Private Issuer
8:01am